Exploration of Targeted Anti-tumor Therapy : Impact Factor & More
eISSN: 2692-3114
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Exploration of Targeted Anti-tumor Therapy
Exploration of Targeted Anti-tumor Therapy Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Open Exploration Publishing Inc. |
| Language | English |
| Publication Time | 13 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 13 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Exploration of Targeted Anti-tumor Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Exploration of Targeted Anti-tumor Therapy
Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society
- 5 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Liquid biopsy in breast cancer: current biomarker platforms and clinical applications
- 5 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model
- 5 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer
- 4 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Targeting tumor transition windows
- 30 Jul 2026
- Exploration of Targeted Anti-tumor Therapy
Comparative outcomes of open, laparoscopic, and robot-assisted radical cystectomy using IPTW-adjusted trifecta and pentafecta metrics
- 29 Jul 2026
- Exploration of Targeted Anti-tumor Therapy
Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society
- 5 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Liquid biopsy in breast cancer: current biomarker platforms and clinical applications
- 5 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model
- 5 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer
- 4 Aug 2026
- Exploration of Targeted Anti-tumor Therapy
Targeting tumor transition windows
- 30 Jul 2026
- Exploration of Targeted Anti-tumor Therapy
Comparative outcomes of open, laparoscopic, and robot-assisted radical cystectomy using IPTW-adjusted trifecta and pentafecta metrics
- 29 Jul 2026
- Exploration of Targeted Anti-tumor Therapy
FAQs on Exploration of Targeted Anti-tumor Therapy
How many articles did Exploration of Targeted Anti-tumor Therapy publish last year? 
Who is the publisher of Exploration of Targeted Anti-tumor Therapy?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations